A dose-response study on urethane carcinogenesis in rats and mice
✍ Scribed by D. Schmähl; R. Port; J. Wahrendorf
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- French
- Weight
- 384 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Sprague‐Dawley rats and NMRI mice were treated with urethane in the drinking water for 2 years. In both species the daily doses were: 100, 500, 2,500, and 12,500 μg/kg. The frequency of animals with malignancies increased steadily with increasing doses, beginning from 500 μg/kg/day for rats, and from 100 μg/kg/day for mice. To evaluate the possible cancer risk for man due to urethane in beverages, the observed response rates were used to extrapolate responses at lower doses. At a daily dose of 0.14 μg/kg/day (corresponding to daily consumption of a beverage with 10 ppb urethane by a 70‐kg man) the upper risk limits were estimated to be 3.2 in 100,000 for rats, and 470 in 100,000 for mice (modified Mantel‐Bryan procedure). Problems in calculating a possible cancer risk for man on the basis of animal observations are discussed. Since treatment of beverages with diethyldicarbonate leads to the formation of urethane, and since a cancer risk to man from urethane cannot be excluded, replacement of diethyldicarbonate by a toxicologically unobjectionable compound is called for.
📜 SIMILAR VOLUMES
and 2 subcutaneous injections vf 0.75 ml iron-dextran (" ltnferon ") at weekly intervals: 64 untreated rats served as controls. Injection site tumours arose in 8, I I , 7 and 8 rats, respectively, in the four groups treated with iron-dextran. The average time of tumour induction was similar in the f
In the A/J strain of mice, urethane (ethyl carbamate) induces lung hyperplasia, adenoma, and adenocarcinoma in a time-dependent manner. These distinct morphological stages may correlate with sequential molecular genetic changes in this mouse model. To test this hypothesis, we investigated the presen
In a randomised, three-period crossover study, psychomotor performance and memory were tested and mood assessed for 3 h after single doses of placebo (PL), 20 mg temazepam (T20) or 30 mg temazepam (T30) were given to six healthy females aged 21-23. A composite measure of psychomotor speed showed a d